Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernadette Pedersen

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Oncogenesis|September 22, 2018
Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanomaMal Irvine, Ashleigh Stewart, Bernadette Pedersen, et al.
Exploration (Beijing, China)|June 16, 2023
SERS characterization of colorectal cancer cell surface markers upon anti-EGFR treatmentNana Lyu, Bernadette Pedersen, Elena Shklovskaya, et al.
Journal of Biophotonics|January 22, 2024
Towards label-free non-invasive autofluorescence multispectral imaging for melanoma diagnosisAline Knab, Ayad G Anwer, Bernadette Pedersen, et al.
Oncoimmunology|March 11, 2026
Prednisolone modulates CD8⁺ and regulatory T-cell activity to dampen response to immune checkpoint inhibitor therapy in melanomaJesse R Brown, Bernadette Pedersen, Georgina V Long, et al.
Cancer Gene Therapy|March 30, 2022
Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signalingJohn J Park, Ashleigh Stewart, Mal Irvine, et al.
Cancers|October 14, 2022
Durable Responses to Anti-PD1 and Anti-CTLA4 in a Preclinical Model of Melanoma Displaying Key Immunotherapy Response BiomarkersElena Shklovskaya, Bernadette Pedersen, Ashleigh Stewart, et al.
International Journal of Cancer|December 7, 2023
Ex vivo tissue modelling informs drug selection for rare cancersJenny H Lee, Zizhen Ming, Veronica K Y Cheung, et al.
Ebiomedicine|August 31, 2024
Single-cell RNA sequencing reveals melanoma cell state-dependent heterogeneity of response to MAPK inhibitorsSu Yin Lim, Yingxin Lin, Jenny H Lee, et al.
Journal of Cellular Physiology|April 19, 2017
The endoplasmic reticulum-associated protein, OS-9, behaves as a lectin in targeting the immature calcium-sensing receptorBryan K Ward, Sarah L Rea, Aaron L Magno, et al.
The Journal of Investigative Dermatology|February 3, 2023
IFN-γ Signaling Sensitizes Melanoma Cells to BH3 MimeticsZizhen Ming, Su Yin Lim, Ashleigh Stewart, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Oncogenesis|September 22, 2018
Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanomaMal Irvine, Ashleigh Stewart, Bernadette Pedersen, et al.
Exploration (Beijing, China)|June 16, 2023
SERS characterization of colorectal cancer cell surface markers upon anti-EGFR treatmentNana Lyu, Bernadette Pedersen, Elena Shklovskaya, et al.
Journal of Biophotonics|January 22, 2024
Towards label-free non-invasive autofluorescence multispectral imaging for melanoma diagnosisAline Knab, Ayad G Anwer, Bernadette Pedersen, et al.
Oncoimmunology|March 11, 2026
Prednisolone modulates CD8⁺ and regulatory T-cell activity to dampen response to immune checkpoint inhibitor therapy in melanomaJesse R Brown, Bernadette Pedersen, Georgina V Long, et al.
Cancer Gene Therapy|March 30, 2022
Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signalingJohn J Park, Ashleigh Stewart, Mal Irvine, et al.
Cancers|October 14, 2022
Durable Responses to Anti-PD1 and Anti-CTLA4 in a Preclinical Model of Melanoma Displaying Key Immunotherapy Response BiomarkersElena Shklovskaya, Bernadette Pedersen, Ashleigh Stewart, et al.
International Journal of Cancer|December 7, 2023
Ex vivo tissue modelling informs drug selection for rare cancersJenny H Lee, Zizhen Ming, Veronica K Y Cheung, et al.
Ebiomedicine|August 31, 2024
Single-cell RNA sequencing reveals melanoma cell state-dependent heterogeneity of response to MAPK inhibitorsSu Yin Lim, Yingxin Lin, Jenny H Lee, et al.
Journal of Cellular Physiology|April 19, 2017
The endoplasmic reticulum-associated protein, OS-9, behaves as a lectin in targeting the immature calcium-sensing receptorBryan K Ward, Sarah L Rea, Aaron L Magno, et al.
The Journal of Investigative Dermatology|February 3, 2023
IFN-γ Signaling Sensitizes Melanoma Cells to BH3 MimeticsZizhen Ming, Su Yin Lim, Ashleigh Stewart, et al.
Pageof 2